Similarly, Yishen capsule was found to improve podocyte injury in rats with DN by decreasing urine protein, increasing SIRT1, LC3-II, and Beclin-1 expression both in vitro and in vivo. The gene discussed is BECN1; the disease is liver dysplastic nodule.